Translating discoveries as novel biomarkers and interventions in ophthalmology

Affiliations

¹ Save Sight Institute, University of Sydney, Sydney, NSW, 2006, Australia. geoffrey.broadhead@sydney.edu.au.
² School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, UNSW, Sydney, 2031, Australia.

Editorial

Geoffrey K Broadhead et al. J Transl Med. 2023.

. 2023 Jun 13;21(1):386.

doi: 10.1186/s12967-023-04216-1.

¹ Save Sight Institute, University of Sydney, Sydney, NSW, 2006, Australia. geoffrey.broadhead@sydney.edu.au.
² School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, UNSW, Sydney, 2031, Australia.

No abstract available

Conflict of interest statement

The authors declare that they have no competing interests.

1. Wang L, Zhang H. Ocular barriers as a double-edged sword: preventing and facilitating drug delivery to the retina. Drug Deliv Transl Res. 2023;13:547–567. doi: 10.1007/s13346-022-01231-5. - DOI - PubMed
1. Tian B, Bilsbury E, Doherty S, et al. Ocular drug delivery: advancements and innovations. Pharmaceutics. 2022;14:1931. doi: 10.3390/pharmaceutics14091931. - DOI - PMC - PubMed
1. Shastri DH, Silva AC, Ameida H. Ocular delivery of therapeutic proteins: a review. Pharmaceutics. 2023;15:205. doi: 10.3390/pharmaceutics15010205. - DOI - PMC - PubMed
1. Altman J, Jones G, Ahmed S, et al. Tear film micrornas as potential biomarkers: a review. Int J Mol Sci. 2023;24:3694. doi: 10.3390/ijms24043694. - DOI - PMC - PubMed
1. Mason RH, Minaker SA, Lahaie Luna G, et al. Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systemic review and meta-analysis. Eye. 2022 doi: 10.1038/s41433-022-02127-x. - DOI - PubMed